Nutanix Reports First Quarter Fiscal 2017 Financial Results
Rapid Adoption of Nutanix Enterprise Cloud Operating System Drives Record Quarterly Revenue and Billings
First Quarter Fiscal Year 2017 Financial Highlights
- Revenue:
$166.8 million , growing 90.1% year-over-year from$87.8 million in the first quarter of fiscal 2016 - Billings:
$239.8 million , growing 86.9% year-over-year from$128.3 million in the first quarter of fiscal 2016 - Net Loss: GAAP net loss of
$162.2 million , compared with a net loss of$38.5 million in the first quarter of fiscal 2016; Non-GAAP net loss of$47.8 million , compared to a net loss of$32.4 million in the first quarter of fiscal 2016 - Net Loss Per Share: GAAP loss per share of
$(2.18) , compared to a net loss per share of$(0.90) in the first quarter of fiscal 2016; Pro forma non-GAAP net loss per share of$(0.37) , compared to a pro forma non-GAAP net loss per share of$(0.27) in the first quarter of fiscal 2016 - Cash and Short-term investments:
$347.1 million , up 154.9% from the first quarter of fiscal 2016 - Deferred Revenue:
$375.4 million , up 160.5% from the first quarter of fiscal 2016 - Operating Cash Flow:
$4.2 million , compared to$(5.6) million in the first quarter of fiscal 2016 - Free Cash Flow:
$(7.8) million , compared to$(15.3) million in the first quarter of fiscal 2016
Reconciliations between GAAP and non-GAAP financial measures and key performance measures are provided in the tables of this press release.
"The time warp between an enterprise-friendly
“The backdrop of our
Recent Company Highlights
- Customer growth:
Nutanix ended the first quarter of fiscal 2017 with a total of 4,473 end-customers, adding a total of 705 end-customers during the quarter. - Large deals increasing: Large end-customers continue to invest in
Nutanix , with cumulative end-customers with lifetime bookings over$1 million growing to 256 in the quarter. - Expanded platform to deliver one-click networks: The company recently announced new and planned capabilities including network visualization, orchestration and security, which will further increase the value of the Nutanix Enterprise Cloud operating system and extend the company’s competitive differentiation.
- Completed acquisitions of PernixData and Calm.io: The addition of PernixData and Calm.io will enable the company to accelerate and further automate the delivery of its Enterprise Cloud operating system.
- Once again named a Leader in Gartner’s Magic Quadrant: For the second consecutive year,
Nutanix was recognized as a Leader in theGartner, Inc. October 2016 Magic Quadrant for Integrated Systems.1 - Hosted 1,200+ Attendees at .NEXT
Europe : The inaugural .NEXT Conference Europe, held inVienna, Austria , marked the company's second largest user event in its history. - Renewed Dell OEM Agreement: Signed an extension to the Dell OEM Agreement, which now runs through
June 2021 , providingDell /EMC sellers and channel partners with uninterrupted access toNutanix software onDell hardware. - Initial Public Offering: Completed its initial public offering, becoming listed on the NASDAQ Stock Exchange on September 30, 2016 and selling 17.1 million shares at
$16 per share.
Q2 Fiscal 2017 Financial Outlook
For the second quarter of fiscal 2017,
- Revenues between
$175 and $180 million ; - Non-GAAP gross margin of approximately 60.0%, and
- Non-GAAP loss per share between
$(0.35) and $(0.36) , using 142 million weighted shares outstanding.
Supplementary materials to this earnings release, including the company’s first quarter fiscal 2017 investor presentation, can be found at http://ir.nutanix.com/company/financial/.
All forward-looking non-GAAP financial measures contained in this section titled "Q2 Fiscal 2017 Financial Outlook" exclude stock-based compensation expense, and may also exclude, as applicable, other special items. We have not reconciled guidance for non-GAAP gross margin and non-GAAP loss per share to their most directly comparable GAAP measures because such items that impact these measures are not within our control and are subject to constant change. While the actual amounts of such items will have a significant impact on the company’s non-GAAP gross margin and non-GAAP loss per share, a reconciliation of the non-GAAP financial measure guidance to the corresponding GAAP measures is not available without unreasonable effort.
1 Source:
Webcast and Conference Call Information
Non-GAAP Financial Measures and Other Key Performance Measures
To supplement our condensed consolidated financial statements, which are prepared and presented in accordance with GAAP, we use the following non-GAAP financial and other key performance measures: billings, non-GAAP gross margin percentage, non-GAAP net loss, pro forma non-GAAP net loss per share, and free cash flow. In computing these non-GAAP financial measures, we exclude certain items such as stock-based compensation and the related income tax impact, costs associated with our acquisitions (such as amortization of acquired intangible assets, revaluation of contingent consideration, income tax related impact, and other acquisition-related costs), loss on debt extinguishment, and changes in the fair value of our preferred stock warrant liability. Billings is a performance measure which our management believes provides useful information to investors because it represents the amounts under binding purchase orders received by us during a given period that have been billed, and we calculate billings by adding the change in deferred revenue between the start and end of the period to total revenue recognized in the same period. Free cash flow is a performance measure that our management believes provides useful information to management and investors about the amount of cash generated by the business after necessary capital expenditures, and we define free cash flow as net cash (used in) provided by operating activities less purchases of property and equipment. We use these non-GAAP financial and key performance measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. Our management believes that these non-GAAP financial measures provide meaningful supplemental information regarding our performance and liquidity by excluding certain expenses and expenditures such as stock-based compensation expense that may not be indicative of our ongoing core business operating results. However, these non-GAAP financial and key performance measures have limitations as analytical tools, and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. Billings, non-GAAP gross margin percentage, non-GAAP net loss, pro forma non-GAAP net loss per share, and free cash flow are not substitutes for total revenue, gross profit, net loss, net loss per share, or net cash (used in) provided by operating activities, respectively. In addition, other companies, including companies in our industry, may calculate non-GAAP financial measures and key performance measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures and key performance measures as tools for comparison. We urge you to review the reconciliation of our non-GAAP financial measures and key performance measures to the most directly comparable GAAP financial measures included below in the tables captioned “Reconciliation of Revenue to Billings,” “Reconciliation of GAAP to Non-GAAP Profit Measures,” and “Reconciliation of GAAP Net Cash (Used In) Provided By Operating Activities to Non-GAAP Free Cash Flow,” and not to rely on any single financial measure to evaluate our business.
Forward Looking Statements
This press release contains express and implied forward-looking statements, including but not limited to statements relating to our business plans and objectives, product features and technology that are under development or in process, such as additional security capabilities, our plans to introduce product features in the future, the impact of the recent PernixData and Calm.io acquisitions on our business, our competitive differentiation, and anticipated future financial results, including but not limited to our guidance on estimated revenues, non-GAAP gross margin, and non-GAAP net loss per share for future fiscal periods. These forward-looking statements are not historical facts, and instead are based on our current expectations, estimates, opinions and beliefs. Consequently, you should not rely on these forward-looking statements. The accuracy of such forward-looking statements depends upon future events, and involves risks, uncertainties and other factors beyond our control that may cause these statements to be inaccurate and cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by such statements, including, among others: the rapid evolution of the markets in which we compete; our ability to sustain or manage future growth effectively; factors that could result in the significant fluctuation of our future quarterly operating results, including, among other things, our revenue mix, the timing and magnitude of orders, shipments and acceptance of our solutions in any given quarter, our ability to attract new and retain existing end-customers, and fluctuations in demand and competitive pricing pressures for our solutions; our ability to successfully integrate acquired companies, employees and intellectual property; failure to develop, or unexpected difficulties or delays in developing, new product features or technology on a timely or cost-effective basis or at all; delays in or lack of customer or market acceptance of our new product features or technology; the introduction, or acceleration of adoption of, competing solutions, including public cloud infrastructure; and other risks detailed in our prospectus filed with the
About
© 2016
NUTANIX, INC. | ||||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||||
(In thousands, unaudited) |
||||||||||
As of | ||||||||||
July 31, | October 31, | |||||||||
2016 | 2016 | |||||||||
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | $ | 99,209 | $ | 225,463 | ||||||
Short-term investments | 85,991 | 121,649 | ||||||||
Accounts receivable—net | 110,659 | 147,707 | ||||||||
Deferred commissions—current | 17,864 | 19,398 | ||||||||
Prepaid expenses and other current assets | 16,138 | 16,304 | ||||||||
Total current assets | 329,861 | 530,521 | ||||||||
Property and equipment—net | 42,218 | 46,328 | ||||||||
Intangible assets—net | — | 27,825 | ||||||||
Goodwill | — | 16,784 | ||||||||
Deferred commissions—non-current | 19,029 | 22,125 | ||||||||
Other assets—non-current | 7,978 | 4,680 | ||||||||
Total assets | $ | 399,086 | $ | 648,263 | ||||||
Liabilities, Convertible Preferred Stock and Stockholders’ (Deficit) Equity | ||||||||||
Current liabilities: | ||||||||||
Accounts payable | $ | 52,111 | $ | 57,308 | ||||||
Accrued compensation and benefits | 24,547 | 28,352 | ||||||||
Accrued expenses and other liabilities | 5,537 | 6,591 | ||||||||
Deferred revenue—current | 130,569 | 165,833 | ||||||||
Total current liabilities | 212,764 | 258,084 | ||||||||
Deferred revenue—non-current | 165,896 | 209,598 | ||||||||
Senior notes | 73,260 | — | ||||||||
Convertible preferred stock warrant liability | 9,679 | — | ||||||||
Early exercised stock options liability | 2,320 | 1,874 | ||||||||
Other liabilities—non-current | 1,103 | 7,044 | ||||||||
Total liabilities | 465,022 | 476,600 | ||||||||
Convertible preferred stock: | ||||||||||
Convertible preferred stock | 310,379 | — | ||||||||
Stockholders’ (deficit) equity: | ||||||||||
Common stock | 1 | 4 | ||||||||
Additional paid-in capital | 65,629 | 775,667 | ||||||||
Accumulated other comprehensive loss | (12 | ) | (20 | ) | ||||||
Accumulated deficit | (441,933 | ) | (603,988 | ) | ||||||
Total stockholders’ (deficit) equity | (376,315 | ) | 171,663 | |||||||
Total liabilities, convertible preferred stock and stockholders’ (deficit) equity | $ | 399,086 | $ | 648,263 | ||||||
NUTANIX, INC. | ||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||
(In thousands, except share and per share data, unaudited) | ||||||||||
Three Months Ended | ||||||||||
October 31, | ||||||||||
2015 | 2016 | |||||||||
Revenue: | ||||||||||
Product | $ | 70,396 | $ | 129,657 | ||||||
Support and other services | 17,360 | 37,152 | ||||||||
Total revenue | 87,756 | 166,809 | ||||||||
Cost of revenue: | ||||||||||
Product (1) | 27,657 | 52,210 | ||||||||
Support and other services (1) | 7,422 | 17,552 | ||||||||
Total cost of revenue | 35,079 | 69,762 | ||||||||
Gross profit | 52,677 | 97,047 | ||||||||
Operating expenses: | ||||||||||
Sales and marketing (1) | 58,599 | 128,775 | ||||||||
Research and development (1) | 23,857 | 75,281 | ||||||||
General and administrative (1) | 7,375 | 29,372 | ||||||||
Total operating expenses | 89,831 | 233,428 | ||||||||
Loss from operations | (37,154 | ) | (136,381 | ) | ||||||
Other expense—net | (871 | ) | (25,712 | ) | ||||||
Loss before provision for income taxes | (38,025 | ) | (162,093 | ) | ||||||
Provision for income taxes | 520 | 76 | ||||||||
Net loss | $ | (38,545 | ) | $ | (162,169 | ) | ||||
Net loss per share attributable to common stockholders—basic and diluted | $ | (0.90 | ) | $ | (2.18 | ) | ||||
Weighted-average shares used in computing net loss per share attributable to common stockholders—basic and diluted | 42,838,933 | 74,373,788 | ||||||||
(1) Includes the following stock-based compensation expense: | ||||||||||
Product cost of sales | $ | 109 | $ | 966 | ||||||
Support cost of sales | 293 | 3,350 | ||||||||
Sales and marketing | 2,118 | 33,891 | ||||||||
Research and development | 1,629 | 34,026 | ||||||||
General and administrative | $ | 1,237 | 18,495 | |||||||
$ | 5,386 | $ | 90,728 | |||||||
During the three months ended October 31, 2016, we recorded (i) approximately $83.0 million of stock-based compensation related to our stock awards with performance conditions, which vesting is subject to continuous service with us and satisfaction of certain liquidity events or/and achievement of specified performance targets, as the vesting of these stock awards became probable and (ii) approximately $2.5 million of stock-based compensation expense related to our ESPP plan, which we began offering upon the effectiveness of our IPO. |
||||||||||
NUTANIX, INC. | ||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||||
(In thousands, unaudited) | ||||||||||
Three Months Ended | ||||||||||
October 31, | ||||||||||
2015 | 2016 | |||||||||
Cash flows from operating activities: | ||||||||||
Net loss | $ | (38,545 | ) | $ | (162,169 | ) | ||||
Adjustments to reconcile net loss to net cash (used in) provided by operating activities: |
||||||||||
Depreciation and amortization | 5,557 | 8,572 | ||||||||
Stock-based compensation | 5,386 | 90,728 | ||||||||
Loss on debt extinguishment | — | 3,320 | ||||||||
Change in fair value of convertible preferred stock warrant liability | 771 | 21,133 | ||||||||
Other | (328 | ) | 369 | |||||||
Changes in operating assets and liabilities: | ||||||||||
Accounts receivable—net | (8,816 | ) | (36,213 | ) | ||||||
Deferred commission | (4,529 | ) | (4,630 | ) | ||||||
Prepaid expenses and other assets | (419 | ) |
840 |
|||||||
Accounts payable | (5,864 | ) | 5,052 | |||||||
Accrued compensation and benefits | (125 | ) | 3,518 | |||||||
Accrued expenses and other liabilities | 763 |
682 |
||||||||
Deferred revenue | 40,533 | 72,958 | ||||||||
Net cash (used in) provided by operating activities | (5,616 | ) | 4,160 | |||||||
Cash flows from investing activities: | ||||||||||
Purchases of investments | (14,066 | ) | (87,448 | ) | ||||||
Maturities of investments | 15,225 | 19,950 | ||||||||
Sales of investments | — | 31,638 | ||||||||
Payments for business acquisitions, net of cash acquired | — | (184 | ) | |||||||
Purchases of property and equipment | (9,642 | ) | (11,915 | ) | ||||||
Net cash used in investing activities | (8,483 | ) | (47,959 | ) | ||||||
Cash flows from financing activities: | ||||||||||
Proceeds from initial public offering, net of underwriting discounts and commissions | — | 254,455 | ||||||||
Payments of offering costs | (803 | ) | (2,243 | ) | ||||||
Proceeds from exercise of stock options, net of repurchases | 1,298 | 1,472 | ||||||||
Repayment of senior notes | — | (75,000 | ) | |||||||
Debt extinguishment costs | — | (1,580 | ) | |||||||
Payment of debt assumed in a business acquisition | — | (7,124 | ) | |||||||
Other | 586 | 73 | ||||||||
Net cash provided by financing activities | 1,081 | 170,053 | ||||||||
Net (decrease) increase in cash and cash equivalents | (13,018 | ) | 126,254 | |||||||
Cash and cash equivalents—beginning of period | 67,879 | 99,209 | ||||||||
Cash and cash equivalents—end of period | $ | 54,861 | $ | 225,463 | ||||||
Supplemental disclosures of cash flow information: | ||||||||||
Cash paid for income taxes | $ | 828 | $ | 698 | ||||||
Cash paid for interest | $ | — | $ | 1,271 | ||||||
Supplemental disclosures of non-cash investing and financing information: | ||||||||||
Vesting of early exercised stock options | $ | 1,049 | $ | 499 | ||||||
Purchases of property and equipment included in accounts payable | $ | 5,308 | $ | 5,033 | ||||||
Offering costs included in accounts payable | $ | 1,772 | $ | 367 | ||||||
Conversion of convertible preferred stock to common stock, net of issuance costs | $ | — | $ | 310,379 | ||||||
Reclassification of convertible preferred stock warrant liability to additional paid-in capital | $ | — | $ | 30,812 | ||||||
Issuance of common stock for business acquisitions | $ | — | $ | 27,063 | ||||||
Reconciliation of Revenue to Billings | |||||||||
(In thousands, unaudited) | |||||||||
Three Months Ended | |||||||||
October 31, | |||||||||
2015 | 2016 | ||||||||
Total revenue | $ | 87,756 | $ | 166,809 | |||||
Change in deferred revenue, net of acquisitions (1) | 40,533 | 72,958 | |||||||
Billings | $ | 128,289 | $ | 239,767 | |||||
(1) Excludes $6.0 million of deferred revenue assumed in the PernixData acquisition. | |||||||||
Reconciliation of GAAP to Non-GAAP Profit Measures |
|||||||||||||||||||||||||||||||||||||||||||||
(Dollars in thousands, unaudited) |
|||||||||||||||||||||||||||||||||||||||||||||
GAAP | Non-GAAP Adjustments | Non-GAAP | |||||||||||||||||||||||||||||||||||||||||||
Q1 2017 | (1) | (2) | (3) | (4) | (5) | (6) | (7) | Q1 2017 | |||||||||||||||||||||||||||||||||||||
Gross profit | $ | 97,047 | $ | 4,316 | $ | 242 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 101,605 | |||||||||||||||||||||||||||
Gross margin | 58.2 | % | 2.6 | % | 0.1 | % | — | % | — | % | — | % | — | % | — | % | 60.9 | % | |||||||||||||||||||||||||||
Operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||
Sales and marketing | $ | 128,775 | $ | (33,891 | ) | $ | (167 | ) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 94,717 | |||||||||||||||||||||||||
Research and development | 75,281 | (34,026 | ) | — | — | — | — | — | — | 41,255 | |||||||||||||||||||||||||||||||||||
General and administrative | 29,372 | (18,495 | ) | — | (672 | ) | (186 | ) | — | — | — | 10,019 | |||||||||||||||||||||||||||||||||
Total operating expenses | $ | 233,428 | $ | (86,412 | ) | $ | (167 | ) | $ | (672 | ) | $ | (186 | ) | $ | — | $ | — | $ | — | $ | 145,991 | |||||||||||||||||||||||
Loss from operations | $ | (136,381 | ) | $ | 90,728 | $ | 409 | $ | 672 | $ | 186 | $ | — | $ | — | $ | — | $ | (44,386 | ) | |||||||||||||||||||||||||
Net loss | $ | (162,169 | ) | $ | 90,728 | $ | 409 | $ | 672 | $ | 186 | $ | 21,133 | $ | 3,320 | $ | (2,109 | ) | $ | (47,830 | ) | ||||||||||||||||||||||||
Weighted-shares outstanding, basic and diluted | 74,373,788 | 74,373,788 | |||||||||||||||||||||||||||||||||||||||||||
Pro forma adjustment | 53,921,394 | 53,921,394 | |||||||||||||||||||||||||||||||||||||||||||
Pro forma weighted-shares outstanding, basic and diluted | 128,295,182 | 128,295,182 | |||||||||||||||||||||||||||||||||||||||||||
Net loss per share, basic and diluted | $ | (2.18 | ) | ||||||||||||||||||||||||||||||||||||||||||
Pro forma net loss per share, basic and diluted | $ | (1.26 | ) | $ | 0.71 | $ | 0.00 | $ | 0.01 | $ | 0.00 | $ | 0.16 | $ | 0.03 | $ | (0.02 | ) | $ | (0.37 | ) | ||||||||||||||||||||||||
(1) Stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||
(2) Amortization of intangible assets | |||||||||||||||||||||||||||||||||||||||||||||
(3) Acquisition-related costs |
|||||||||||||||||||||||||||||||||||||||||||||
(4) Change in fair value of contingent consideration assumed in the PernixData acquisition | |||||||||||||||||||||||||||||||||||||||||||||
(5) Change in fair value of preferred stock warrant liability | |||||||||||||||||||||||||||||||||||||||||||||
(6) Loss on debt extinguishment | |||||||||||||||||||||||||||||||||||||||||||||
(7) Partial release of valuation allowance from the PernixData acquisition and the tax effect of stock-based compensation expense | |||||||||||||||||||||||||||||||||||||||||||||
GAAP | Non-GAAP Adjustments | Non-GAAP | ||||||||||||||||||
Q1 2016 | (1) | (2) | Q1 2016 | |||||||||||||||||
Gross profit | $ | 52,677 | $ | 402 | $ | — | $ | 53,079 | ||||||||||||
Gross margin | 60.0 | % | 0.5 | % | — | % | 60.5 | % | ||||||||||||
Operating expenses: | ||||||||||||||||||||
Sales and marketing | $ | 58,599 | $ | (2,118 | ) | $ | — | $ | 56,481 | |||||||||||
Research and development | 23,857 | (1,629 | ) | — | 22,228 | |||||||||||||||
General and administrative | 7,375 | (1,237 | ) | — | 6,138 | |||||||||||||||
Total operating expenses | $ | 89,831 | $ | (4,984 | ) | $ | — | $ | 84,847 | |||||||||||
Loss from operations | $ | (37,154 | ) | $ | 5,386 | $ | — | $ | (31,768 | ) | ||||||||||
Net loss | $ | (38,545 | ) | $ | 5,386 | $ |
771 |
$ |
(32,388 |
) | ||||||||||
Weighted-shares outstanding, basic and diluted | 42,838,933 | 42,838,933 | ||||||||||||||||||
Pro forma adjustment | 76,319,511 | 76,319,511 | ||||||||||||||||||
Pro forma weighted-shares outstanding, basic and diluted | 119,158,444 | 119,158,444 | ||||||||||||||||||
Net loss per share, basic and diluted | $ | (0.90 | ) | |||||||||||||||||
Pro forma net loss per share, basic and diluted | $ | (0.32 | ) | $ | 0.05 | $ |
0.01 |
$ | (0.27 | ) | ||||||||||
(1) Stock-based compensation expense | ||||||||||||||||||||
(2) Change in fair value of preferred stock warrant liability | ||||||||||||||||||||
Reconciliation of GAAP Net Cash (Used In) Provided By Operating Activities to Non-GAAP Free Cash Flow |
||||||||||
(In thousands, unaudited) | ||||||||||
Three Months Ended | ||||||||||
October 31, | ||||||||||
2015 | 2016 | |||||||||
Net cash (used in) provided by operating activities | $ | (5,616 | ) | $ | 4,160 | |||||
Purchases of property and equipment | (9,642 | ) | (11,915 | ) | ||||||
Free cash flow | $ | (15,258 | ) | $ | (7,755 | ) | ||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20161129006172/en/
Source:
Nutanix, Inc.
Investor Contact:
Tonya Chin, 408-560-2675
tonya@nutanix.com
or
Media Contact:
Kate Reed, 973-534-9292
kreed@nutanix.com